BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7556308)

  • 1. Estimation of brain 5HT2 receptor binding potential with a single-dose PET paradigm.
    Petit Taboué MC; Baron JC
    Eur J Nucl Med; 1995 Jun; 22(6):585-6. PubMed ID: 7556308
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography.
    Biver F; Goldman S; Luxen A; Monclus M; Forestini M; Mendlewicz J; Lotstra F
    Eur J Nucl Med; 1994 Sep; 21(9):937-46. PubMed ID: 7995287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study.
    Biver F; Lotstra F; Monclus M; Dethy S; Damhaut P; Wikler D; Luxen A; Goldman S
    Nucl Med Biol; 1997 May; 24(4):357-60. PubMed ID: 9257335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder.
    Larisch R; Klimke A; Mayoral F; Hamacher K; Herzog HR; Vosberg H; Tosch M; Gaebel W; Rivas F; Coenen HH; Müller-Gärtner HW
    Nuklearmedizin; 2001 Aug; 40(4):129-34. PubMed ID: 11556203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
    Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
    van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB
    J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.
    Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
    Larisch R; Klimke A; Hamacher K; Henning U; Estalji S; Hohlfeld T; Vosberg H; Tosch M; Gaebel W; Coenen HH; Müller-Gärtner HW
    Behav Brain Res; 2003 Feb; 139(1-2):21-9. PubMed ID: 12642173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex difference in 5HT2 receptor in the living human brain.
    Biver F; Lotstra F; Monclus M; Wikler D; Damhaut P; Mendlewicz J; Goldman S
    Neurosci Lett; 1996 Feb; 204(1-2):25-8. PubMed ID: 8929969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis.
    Petit-Taboué MC; Landeau B; Osmont A; Tillet I; Barré L; Baron JC
    J Nucl Med; 1996 Jan; 37(1):95-104. PubMed ID: 8544011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and.
    Soares JC; van Dyck CH; Tan P; Zoghbi SS; Garg P; Soufer R; Baldwin RM; Fujita M; Staley JK; Fu X; Amici L; Seibyl J; Innis RB
    Psychiatry Res; 2001 Apr; 106(2):81-93. PubMed ID: 11306248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
    Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
    Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons.
    Price JC; Lopresti BJ; Mason NS; Holt DP; Huang Y; Mathis CA
    Synapse; 2001 Jul; 41(1):1-10. PubMed ID: 11354008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors.
    Maziere B; Crouzel C; Venet M; Stulzaft O; Sanz G; Ottaviani M; Sejourne C; Pascal O; Bisserbe JC
    Int J Rad Appl Instrum B; 1988; 15(4):463-8. PubMed ID: 3255742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.
    Forutan F; Estalji S; Beu M; Nikolaus S; Hamacher K; Coenen HH; Vosberg H; Müller-Gärtner HW; Larisch R
    Nuklearmedizin; 2002; 41(4):197-201. PubMed ID: 12224404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.
    Lemaire C; Cantineau R; Guillaume M; Plenevaux A; Christiaens L
    J Nucl Med; 1991 Dec; 32(12):2266-72. PubMed ID: 1744713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.
    Costes N; Merlet I; Zimmer L; Lavenne F; Cinotti L; Delforge J; Luxen A; Pujol JF; Le Bars D
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):753-65. PubMed ID: 12045674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.